LEXARIA BIOSCIENCE CORP. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
LEXARIA BIOSCIENCE CORP. (LEXX) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $8.27 thousand as of 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-07-13
- 2026-05-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $8.27K.
- 2026-02-28: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9.93K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-05-31 | $8.27K 10-Q · filed 2026-07-13 |
| 2026-02-28 | $9.93K 10-Q · filed 2026-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |